AU Stock MarketDetailed Quotes
DXBO Dimerix Ltd
- 0.200
- 0.0000.00%
20min DelayNot Open Dec 13 10:38 AET
111.57MMarket Cap0.00P/E (Static)
0.200High0.200Low100.00KVolume0.200Open0.200Pre Close20.00KTurnover0.49052wk High0.02%Turnover Ratio557.83MShares0.10052wk Low--EPS TTM87.43MFloat Cap0.490Historical High0.00P/E (Static)437.17MShs Float0.015Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Dimerix Ltd Company
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
Company Profile
SymbolDXBO
Company NameDimerix Ltd
Founded1975
MarketASX
Employees12
Fiscal Year Ends06-30
Address425 Smith Street
CityFitzroy
CountryAustralia
Zip Code3065
Phone+61 1300813321
Websitehttps://www.dimerix.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Nina Webster
- Chief Executive Officer,Managing Director
- --
- Clinton Snow
- Non-Executive Director
- --
- Sonia Maria Poli
- Non-Executive Director
- --
- Mark P Diamond
- Non-Executive Director
- --
- Hugh Alsop
- Non-Executive Director
- --
Heat List
AU
Overall
Symbol
Price
% Chg
No Data